Cargando…
A Promising DNA Methylation Signature for the Triage of High-Risk Human Papillomavirus DNA-Positive Women
High-risk human papillomavirus (hrHPV)-DNA testing is frequently performed parallel to cytology for the detection of high-grade dysplasia and cervical cancer particularly in women above 30 years of age. Although highly sensitive, hrHPV testing cannot distinguish between HPV-positive women with or wi...
Autores principales: | Hansel, Alfred, Steinbach, Daniel, Greinke, Christiane, Schmitz, Martina, Eiselt, Juliane, Scheungraber, Cornelia, Gajda, Mieczyslaw, Hoyer, Heike, Runnebaum, Ingo B., Dürst, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960142/ https://www.ncbi.nlm.nih.gov/pubmed/24647315 http://dx.doi.org/10.1371/journal.pone.0091905 |
Ejemplares similares
-
Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive women
por: Schmitz, Martina, et al.
Publicado: (2017) -
Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays
por: Dippmann, Carolin, et al.
Publicado: (2020) -
Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status
por: Dürst, Matthias, et al.
Publicado: (2015) -
Digital-Direct-RT-PCR: a sensitive and specific method for quantification of CTC in patients with cervical carcinoma
por: Pfitzner, Claudia, et al.
Publicado: (2014) -
Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA
por: Carow, Katrin, et al.
Publicado: (2017)